1. Synergy and allostery in ligand binding by HIV-1 Nef
- Author
-
Stefan T. Arold, Audrey Restouin, Yves Collette, Sandrine Opi, Safia Aljedani, Christian Dumas, Mingdong Huang, Luc Ponchon, Xavier Morelli, Umar F. Shahul Hameed, Afaque Ahmad Imtiyaz Momin, Adrien Lugari, Xiaoli Shi, Abdullah Aldehaiman, Luyao Wang, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Paoli-Calmettes, and Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Aix Marseille Université (AMU)
- Subjects
Protein Conformation, alpha-Helical ,Engineering ,Nef Protein ,viruses ,Human immunodeficiency virus (HIV) ,Gene Expression ,Protein Engineering ,medicine.disease_cause ,Crystallography, X-Ray ,Ligands ,Proto-Oncogene Proteins c-fyn ,Biochemistry ,SH3 domain ,Heterogeneous-Nuclear Ribonucleoprotein K ,0302 clinical medicine ,Structural Biology ,Cloning, Molecular ,Src family ,Research Articles ,0303 health sciences ,allostery ,Chemistry ,030302 biochemistry & molecular biology ,virus diseases ,Nuclear Proteins ,Ligand (biochemistry) ,Recombinant Proteins ,Host-Pathogen Interactions ,Thermodynamics ,Allosteric Site ,18-crown-6 ,Protein Binding ,tertiary recognition ,Allosteric regulation ,Genetic Vectors ,Biophysics ,Crystallographic data ,Library science ,Computational biology ,Molecular Dynamics Simulation ,03 medical and health sciences ,Fetus ,medicine ,Escherichia coli ,Humans ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Protein Interaction Domains and Motifs ,Amino Acid Sequence ,nef Gene Products, Human Immunodeficiency Virus ,Molecular Biology ,Binding selectivity ,030304 developmental biology ,Sequence Homology, Amino Acid ,business.industry ,selectivity ,Computational Biology ,Cell Biology ,Pathogenicity ,Protein Structure, Tertiary ,autoinhibition ,HIV-1 ,Protein Conformation, beta-Strand ,business ,Sequence Alignment ,030217 neurology & neurosurgery - Abstract
The Nef protein of human and simian immunodeficiency viruses (HIV and SIV, respectively) boosts viral pathogenicity through its interactions with host cell proteins. Nef has a folded core domain and large flexible regions, each carrying several protein interaction sites. By combining the polyvalency intrinsic to unstructured regions with the binding selectivity and strength of a 3D folded domain, Nef can bind to many different host cell proteins, perturbing their cellular functions. For example, the combination of a linear proline-rich motif and a hydrophobic core domain surface allows Nef to increase affinity and selectivity for particular Src family SH3 domains. Here we investigated whether the interplay between Nef’s flexible regions and its core domain can allosterically influence ligand selection. We found that the flexible regions can bind back to the core domain in different ways, producing distinct conformational states that alter the SH3 domain selectivity and availability of Nef’s functional motifs. The resulting cross-talk might help synergising certain subsets of ligands while excluding others, promoting functionally coherent Nef-bound protein ensembles. Further, we combined proteomic and bioinformatic analyses to identify human proteins that select SH3 domains in the same way as does Nef. We found that only 2–3% of clones from a whole human fetal library displayed a Nef-like SH3 selectivity. However, in most cases this selectivity appears to be achieved by a canonical linear interaction rather than a Nef-like ‘tertiary’ interaction. This analysis suggests that Nef’s SH3 recognition surface has no (or marginally few) cellular counterparts, validating the Nef tertiary binding surface as a promising unique drug target.
- Published
- 2021
- Full Text
- View/download PDF